Combined angiotensin inhibition raises hyperkalemia, acute kidney injury risks

ATLANTA – The combined use of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker was associated with an increased risk of hyperkalemia and acute kidney injury in patients...